- Filed
- May 6, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q2 2026 · Mar 28, 2026 | 134.36M sh |
| Shares Diluted | Q2 2026 · Mar 28, 2026 | 130.87M sh |
| Shares Diluted | Q2 2026 · Mar 29, 2025 | 107.73M sh |
| Shares Diluted | Q2 2026 · Mar 29, 2025 | 106.9M sh |
| Shares Outstanding | Q2 2026 · Mar 28, 2026 | 602.52M sh |
| Shares Outstanding | Q2 2026 · Dec 27, 2025 | 599.77M sh |
| Shares Outstanding | Q2 2026 · Sep 27, 2025 | 590.89M sh |
| Shares Outstanding | Q2 2026 · Mar 29, 2025 | 588.91M sh |
| Shares Outstanding | Q2 2026 · Dec 28, 2024 | 587.42M sh |
| Shares Outstanding | Q2 2026 · Sep 28, 2024 | 585.96M sh |
| Operating Cash Flow | Q2 2026 · Mar 28, 2026 | $452.88M |
| Operating Cash Flow | Q2 2026 · Mar 29, 2025 | $474.6M |
| Cash And Equivalents | Q2 2026 · Mar 28, 2026 | $2.01B |
| Cash And Equivalents | Q2 2026 · Sep 27, 2025 | $1.24B |
| Cash And Equivalents | Q2 2026 · Mar 29, 2025 | $954.94M |
| Stockholders Equity | Q2 2026 · Mar 28, 2026 | $686.14M |
| Stockholders Equity | Q2 2026 · Sep 27, 2025 | $220.19M |
| Current Liabilities | Q2 2026 · Mar 28, 2026 | $2.02B |
| Current Liabilities | Q2 2026 · Sep 27, 2025 | $1.73B |
| Total Liabilities | Q2 2026 · Mar 28, 2026 | $2.47B |
| Total Liabilities | Q2 2026 · Sep 27, 2025 | $1.92B |
| Current Assets | Q2 2026 · Mar 28, 2026 | $2.92B |
| Current Assets | Q2 2026 · Sep 27, 2025 | $1.88B |
| Total Assets | Q2 2026 · Mar 28, 2026 | $3.5B |
| Total Assets | Q2 2026 · Sep 27, 2025 | $2.4B |
| Eps Diluted | Q2 2026 · Mar 28, 2026 | $0.01 |
| Eps Diluted | Q2 2026 · Mar 28, 2026 | $0.03 |
| Eps Diluted restated | Q2 2026 · Mar 29, 2025 | −$0.02 |
| Eps Diluted restated | Q2 2026 · Mar 29, 2025 | −$0.05 |
| Eps Basic | Q2 2026 · Mar 28, 2026 | $0.02 |
| Eps Basic | Q2 2026 · Mar 28, 2026 | $0.04 |
| Eps Basic restated | Q2 2026 · Mar 29, 2025 | −$0.02 |
| Eps Basic restated | Q2 2026 · Mar 29, 2025 | −$0.05 |
| Sga Expense | Q2 2026 · Mar 28, 2026 | $92.57M |
| Sga Expense | Q2 2026 · Mar 28, 2026 | $173.79M |
| Sga Expense restated | Q2 2026 · Mar 29, 2025 | $73.31M |
| Sga Expense restated | Q2 2026 · Mar 29, 2025 | $134.01M |
| Rd Expense | Q2 2026 · Mar 28, 2026 | $51.28M |
| Rd Expense | Q2 2026 · Mar 28, 2026 | $94.29M |
| Rd Expense restated | Q2 2026 · Mar 29, 2025 | $57.96M |
| Rd Expense restated | Q2 2026 · Mar 29, 2025 | $101.24M |
| Net Income | Q2 2026 · Mar 28, 2026 | $1.97M |
| Net Income | Q2 2026 · Mar 28, 2026 | $4.57M |
| Net Income restated | Q2 2026 · Mar 29, 2025 | −$1.8M |
| Net Income restated | Q2 2026 · Mar 29, 2025 | −$4.98M |
| Operating Income | Q2 2026 · Mar 28, 2026 | $6.09M |
| Operating Income | Q2 2026 · Mar 28, 2026 | $12.62M |
| Operating Income restated | Q2 2026 · Mar 29, 2025 | −$20.47M |
| Operating Income restated | Q2 2026 · Mar 29, 2025 | −$43.44M |
| Gross Profit | Q2 2026 · Mar 28, 2026 | $149.95M |
| Gross Profit | Q2 2026 · Mar 28, 2026 | $283.38M |
| Gross Profit restated | Q2 2026 · Mar 29, 2025 | $110.79M |
| Gross Profit restated | Q2 2026 · Mar 29, 2025 | $191.81M |
| Cost Of Revenue | Q2 2026 · Mar 28, 2026 | $526.53M |
| Cost Of Revenue | Q2 2026 · Mar 28, 2026 | $1.02B |
| Cost Of Revenue restated | Q2 2026 · Mar 29, 2025 | $438.86M |
| Cost Of Revenue restated | Q2 2026 · Mar 29, 2025 | $844.54M |
| Revenue | Q2 2026 · Mar 28, 2026 | $676.48M |
| Revenue | Q2 2026 · Mar 28, 2026 | $1.31B |
| Revenue | Q2 2026 · Mar 29, 2025 | $549.65M |
| Revenue | Q2 2026 · Mar 29, 2025 | $1.04B |